BeOne Medicines Ltd. (ONC)
NASDAQ: ONC · Real-Time Price · USD
294.55
+4.20 (1.45%)
At close: Jul 18, 2025, 4:00 PM
298.25
+3.70 (1.26%)
After-hours: Jul 18, 2025, 7:56 PM EDT
BeOne Medicines Employees
BeOne Medicines had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
$379,624
Profits / Employee
-$35,670
Market Cap
34.95B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ONC News
- 3 days ago - BeOne Medicines to Announce Second Quarter 2025 Financial Results on August 6 - Business Wire
- 9 days ago - European Commission Approves TEVIMBRA® in Combination with Chemotherapy as a First-Line Treatment for Nasopharyngeal Carcinoma - Business Wire
- 10 days ago - Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development - Business Wire
- 23 days ago - BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day - Business Wire
- 24 days ago - BeOne Medicines Receives Positive CHMP Opinion for Tablet Formulation of BRUKINSA® - Business Wire
- 4 weeks ago - BeOne Medicines: Brukinsa Momentum And Pipeline Catalysts Justify Its Premium - Seeking Alpha
- 5 weeks ago - BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025 - Business Wire
- 5 weeks ago - U.S. FDA Approves Tablet Formulation of BeOne's BRUKINSA® for All Approved Indications - Business Wire